COAG Company Profile and Key Details

NASDAQ : COAG

Hemab Therapeutics Common Stock

$39.31

-0.575-1.44%

Open: 3:55 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) stock declined over -1.44%, trading at $39.31 on NASDAQ, down from the previous close of $39.88. The stock opened at $40.26, fluctuating between $39.20 and $42.48 in the recent session.

Stock Snapshot

39.88

Prev. Close

1.84B

Market Cap

39.2

Day Low

-1.64

P/E Ratio

-23.98

EPS (TTM)

N/A

Cash Flow per Share

40.26

Open

46.71M

Number of Shares

42.4843

Day High

N/A

Free Float in %

N/A

Book Value

335.46K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	44.32	44.52	39.49	39.88	433.56K
Sep 09, 2026	44.77	46.20	43.05	44.50	429.14K
Sep 08, 2026	44.03	45.49	43.10	44.57	358.01K
Sep 04, 2026	43.40	45.49	43.29	44.41	302.05K
Sep 03, 2026	44.62	45.28	43.02	44.37	257.21K
Sep 02, 2026	44.51	46.83	42.71	44.70	325.21K
Sep 01, 2026	45.81	47.00	43.34	44.02	318.51K
Aug 31, 2026	44.66	46.43	43.08	45.73	591.6K
Aug 28, 2026	48.84	49.37	44.64	44.84	260.08K
Aug 27, 2026	49.15	51.11	48.61	49.49	354.96K
Aug 26, 2026	49.77	52.00	47.97	49.19	334.19K
Aug 25, 2026	46.67	50.36	46.58	49.65	527.13K
Aug 24, 2026	49.10	50.15	46.46	46.67	336.96K
Aug 21, 2026	48.85	53.00	46.99	49.16	391.76K
Aug 20, 2026	50.76	51.69	46.57	48.20	426.5K
Aug 19, 2026	53.42	54.05	50.85	51.66	279.91K
Aug 18, 2026	53.00	55.37	52.30	52.44	183.05K
Aug 17, 2026	54.78	55.18	51.77	53.59	208.93K
Aug 14, 2026	53.76	55.42	50.59	54.94	101.17K
Aug 13, 2026	54.74	55.18	52.00	53.95	171.4K

Contact Details

Cambridge, MA 02142

United States

https://www.hemab.com 617 553 3952

About Company

Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.

Stock Peers

ARGX

-18.27-1.82%

argenx SE$984.04 REGN

-14.39-1.78%

Regeneron Pharmaceuticals, Inc.$793.26 MDGL

-13.54-2.48%

Madrigal Pharmaceuticals, Inc.$533.12 VRTX

-6.56-1.26%

Vertex Pharmaceuticals Incorporated$514.56 UTHR

-2.96-0.58%

United Therapeutics Corporation$503.86 KRYS

-2.54-0.73%

Krystal Biotech, Inc.$345.55 ONC

-9.2-2.62%

BeOne Medicines AG$341.80 PRAX

-6.73-1.95%

Praxis Precision Medicines, Inc.$338.57 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

1.2+0.42%

Ligand Pharmaceuticals Incorporated$289.25

Frequently Asked Questions

What is the current Hemab Therapeutics Holdings, Inc. Common Stock (COAG) stock price?

Hemab Therapeutics Holdings, Inc. Common Stock (NASDAQ: COAG) stock price is $39.31 in the last trading session. During the trading session, COAG stock reached the peak price of $42.48 while $39.20 was the lowest point it dropped to. The percentage change in COAG stock occurred in the recent session was -1.44% while the dollar amount for the price change in COAG stock was - $0.58.

COAG's industry and sector of operation?

The NASDAQ listed COAG is part of Biotechnology industry that operates in the broader Healthcare sector. Hemab Therapeutics Holdings, Inc. Common Stock designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of COAG?

No Data

How COAG did perform over past 52-week?

COAG's closing price is 73.39% higher than its 52-week low of $23.00 where as its distance from 52-week high of $55.42 is -28.04%.

How many employees does COAG have?

Number of COAG employees currently stands at 59.

Link for COAG official website?

Official Website of COAG is: https://www.hemab.com

How do I contact COAG?

COAG could be contacted at phone 617 553 3952 and can also be accessed through its website. COAG operates from 101 Main Street, Cambridge, MA 02142, United States.

How many shares of COAG are traded daily?

COAG stock volume for the day was 335.46K shares. The average number of COAG shares traded daily for last 3 months was 374.95K.

What is the market cap of COAG currently?

The market value of COAG currently stands at $1.84B with its latest stock price at $39.31 and 46.71M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	59
Beta	1.85
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	59
Beta	1.85
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

COAG Company Profile and Key Details

Hemab Therapeutics Common Stock

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Financial & Profitability Overview

Dividend & Fair Value

Earnings & Analyst Outlook

Technical Performance

Key Takeaways

Price Forecast & Outlook

Valuation Metrics